Navid Radfar: Moving Beyond CHA₂DS₂-VASc and De-Risking Atrial Fibrillation
Navid Radfar, Incoming Cardiology Fellow at Rutgers Health, shared on LinkedIn about a recent article he and his colleagues co-authored, published in American Journal of Cardiovascular Drugs, adding:
”Excited to share our new publication, ‘De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making,’ is now published in the American Journal of Cardiovascular Drugs.
Atrial fibrillation is the most common arrhythmia and a leading cause of stroke.
For years, we’ve decided who needs a blood thinner using one clinical checklist: the CHA₂DS₂-VASc score.
But does it really capture everything about a patient?
It’s practical, widely used, and has helped countless patients — yet it has a blind spot. It treats complex variables as simple yes/no boxes, and it can’t see the structure or function of the heart itself.
In this paper, my co-authors and I make the case for a more personalized approach we call ‘de-risking’ — using advanced imaging (left atrial strain, volume index, and appendage morphology), circulating biomarkers, and AI-enabled tools to refine who truly benefits from anticoagulation, and who may be exposed to bleeding risk without much to gain.
We also synthesize lessons from landmark trials (ARTESIA, NOAH-AFNET 6, and ALONE-AF) that collectively reinforce a key idea: anticoagulation decisions should follow individualized risk–benefit assessment, not arrhythmia detection alone.”
Title: De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making
Authors: Navid Radfar, Dhir Gala, Harsh Singh, Juan Bello, Joseph Allencherril
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 28, 2026, 16:43Scott Sutton: Community and Connection in Immune Thrombocytopenia
-
Sep 28, 2026, 16:24Pankti Solanki: ISBT Recognized JAMA as the 49th Human Blood Group System
-
Sep 28, 2026, 15:52Kassa Tameru: Antithrombotic Management in GI Bleeding and Elective Endoscopy
-
Sep 28, 2026, 15:51Chengappa Kavadichanda: How Do aPLs Change Over Time in Early Lupus?
-
Sep 28, 2026, 15:18Linda Shore-Lesserson: Celebrating 25 Years of PBM at the SABM Meeting
-
Sep 28, 2026, 14:45Access Real-Time Bleeding Disorder Guidelines with the New WFH Resource Hub – WFH
-
Sep 28, 2026, 14:44Subham Banerjee: When Routine Blood Grouping Hid a Rare Diagnosis
-
Sep 28, 2026, 14:41Francois Roubille: Can Low-Dose Colchicine Prevent Atrial Fibrillation After CABG?
-
Sep 28, 2026, 14:39William Aird: Gulliver’s Atlas – Mapping the Evolution of the Vertebrate Red Cell